Table 1 |
|||
|
Non-invasive tests for intestinal and pancreatic digestive-absorptive functions and for intestinal inflammation. |
|||
|
Test |
Normal values |
Implication |
Reference |
|
|
|||
|
α1-antitrypsin concentration |
< 0.9 mg/g |
increased intestinal permeability/protein loss |
Catassi C et al. J Pediatr 1986;109:500-502 |
|
|
|||
|
Steatocrit |
<2.5% (older than 2 years) |
fecal fat loss |
Guarino A et al. J Pediatr Gastroenterol Nutr1992;14:268-274 |
|
|
|||
|
Fecal reducing substances |
absent |
carbohydrate malabsorption |
Lindquist BL et al. Arch Dis Child 1976;51:319-321 |
|
|
|||
|
Elastase concentration |
> 200 ug/g stool |
exocrine pancreatic dysfunction |
Carroccio A et al. Gut 1998;43:558-563 |
|
|
|||
|
Chymotrypsin concentration |
> 7.5 U/g > 375 U/24 h |
exocrine pancreatic dysfunction |
Carroccio A et al. Gastroenterology 1997;112:1839-1844 |
|
|
|||
|
Fecal occult blood |
absent |
fecal blood loss, distal intestinal inflammation |
Fine KD. N Engl J Med 1996;334:1163-1167 |
|
|
|||
|
Calprotectin concentration |
100 ug/g |
intestinal inflammation |
Fagerberg UL et al. J Pediatr Gastroenterol Nutr 2003;37:468-72 |
|
|
|||
|
Fecal leukocytes |
< 5/microscopic field |
colonic inflammation |
Harris JC et al. 1972;76:697-703 |
|
|
|||
|
Nitric oxide in rectal dyalisate |
< 5 uM of NO2-/NO3- |
rectal inflammation |
Berni Canani R et al. Am J Gastroenterol 2002;97:1574-1576 |
|
|
|||
|
Dual sugar (cellobiose/mannitol) absorption test |
Urine excretion ratio: 0.010+0.018 |
Increased intestinal permeability |
Catassi C, et al. J. Pediatr Gastro Nutr 2008;46:41-47 |
|
|
|||
|
Xylose oral load |
25 mg % |
Absorptive surface |
Craig RM, Ehrenpreis ED J Clin Gastroenterol 1999; 29:143-50 |
|
|
|||
|
Iron absorption test |
Based on percentile reference |
De Vizia et al. J. Pediatri Gastroentrol Nutr. 1992;14-21-6 |
|
|
|
|||
|
Spagnuolo et al. Italian Journal of Pediatrics 2009 35:28 doi:10.1186/1824-7288-35-28 |
|||